Not applicableActive Not RecruitingNCT06432660What this trial is testingEye Plaque Brachytherapy for Ocular MelanomaWho this might be right forOcular Melanoma Duke University 42
Large-scale testing (Phase 3)Study completedNCT00072124What this trial is testingDacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV MelanomaWho this might be right forMelanoma (Skin) National Cancer Institute (NCI)
Not applicableEnded earlyNCT02336763What this trial is testingRadiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver MetastasesWho this might be right forIris MelanomaMedium/Large Size Posterior Uveal MelanomaStage IIA Uveal Melanoma+4 more Jonsson Comprehensive Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00020397What this trial is testingVaccine Therapy in Treating Patients With Refractory Metastatic MelanomaWho this might be right forMelanoma (Skin) National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT01638676What this trial is testingA Phase I/II Trial of Vemurafenib and Metformin to Melanoma PatientsWho this might be right forMelanoma University of Louisville 55
Post-approval studies (Phase 4)Study completedNCT01735955What this trial is testingStudy to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored StudyWho this might be right forChronic Myelogenous Leukemia (CML)Metastatic Gastrointestinal Stromal Tumors (GIST)Acute Lymphoblastic Leukemia (ALL)+1 more Novartis Pharmaceuticals 57
Large-scale testing (Phase 3)Study completedNCT01368276What this trial is testingAn Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in MelanomaWho this might be right forMelanoma BioVex Limited 31
Testing effectiveness (Phase 2)Looking for participantsNCT05136196What this trial is testingBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT03107663What this trial is testing⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's LymphomaWho this might be right forPositron-Emission TomographyImmunomodulationMetastatic Solid Malignancies+1 more ImaginAb, Inc. 15
Testing effectiveness (Phase 2)UnknownNCT04200040What this trial is testingA Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma PatientsWho this might be right forMelanoma (Skin) OrienGene Biotechnology Ltd. 165
Testing effectiveness (Phase 2)Study completedNCT01153763What this trial is testingGSK2118436 in BRAF Mutant Metastatic MelanomaWho this might be right forMelanoma GlaxoSmithKline 92
Testing effectiveness (Phase 2)Ended earlyNCT02831933What this trial is testingTrial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal MelanomaWho this might be right forLung Squamous Cell Carcinoma Stage IVNonsquamous Nonsmall Cell Neoplasm of LungMetastatic Uveal Melanoma Eric Bernicker, MD 11
Early research (Phase 1)Study completedNCT04772989What this trial is testingEvaluate AB308 in Combination With AB122 in Participants With Advanced MalignanciesWho this might be right forAdvanced Solid TumorNon Small Cell Lung Cancer (NSCLC)Melanoma+7 more Arcus Biosciences, Inc. 94
Testing effectiveness (Phase 2)UnknownNCT01168050What this trial is testingEfficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas.Who this might be right forMalignant Skin Melanoma T0Stage III MelanomaStage IV Melanoma+1 more Assistance Publique - Hôpitaux de Paris 25
Testing effectiveness (Phase 2)Study completedNCT01064713What this trial is testingPhase II Study of Tesetaxel in Metastatic MelanomaWho this might be right forAdvanced MelanomaCancer M.D. Anderson Cancer Center 17
Not applicableActive Not RecruitingNCT05863052What this trial is testingAnalyzing Clinical Outcomes and Genomic Data of American Indian Patient PopulationWho this might be right forImmune Checkpoint InhibitorsMetastatic Solid TumorNonsmall Cell Lung Cancer+4 more University of Oklahoma 72
Early research (Phase 1)Looking for participantsNCT04913285What this trial is testingEvaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsWho this might be right forSolid Tumor, AdultNon-small Cell Lung CancerMelanoma Pierre Fabre Medicament 400
Early research (Phase 1)Ended earlyNCT03332589What this trial is testingE6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS)Who this might be right forMalignant MelanomaBrain Metastases Spirita Oncology, LLC 4
Testing effectiveness (Phase 2)Ended earlyNCT05219578What this trial is testingRTX-224 Monotherapy in Patients With Solid TumorsWho this might be right forNon Small Cell Lung CancerCutaneous MelanomaHead and Neck Squamous Cell Carcinoma+2 more Rubius Therapeutics 7
Early research (Phase 1)Study completedNCT03159117What this trial is testingPfizer PF-06688992 in Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma Memorial Sloan Kettering Cancer Center 7